PLoS ONE · 2013 · 30 citations · 40 references
Life SciencesImmunologyMolecular BiologyImmunizationVaccine ImmunologyVaccinologyAdaptive Immune ResponsesAntiviral ImmunityHiv Vaccine DevelopmentNucleic Acid VaccinesVaccine PlatformsViral VaccinesAntibodiesAntibody ImmunogenicityAntibody-dependent Cellular CytotoxicityBinding AntibodiesBroadly Neutralizing Antibody InductionDeoxyribonucleic Acid (Dna) VaccineElectroporationT-cell Immune Responses
An effective HIV vaccine will most likely require the induction of strong T-cell responses, broadly neutralizing antibodies (bNAbs), and the elicitation of antibody-dependent cellular cytotoxicity (ADCC). Previously, we demonstrated the induction of strong HIV/SIV cellular immune responses in macaques and humans using synthetic consensus DNA immunogens delivered via adaptive electroporation (EP). However, the ability of this improved DNA approach to prime for relevant antibody responses has not been previously studied. Here, we investigate the immunogenicity of consensus DNA constructs encoding gp140 sequences from HIV-1 subtypes A, B, C and D in a DNA prime-protein boost vaccine regimen. Mice and guinea pigs were primed with single- and multi-clade DNA via EP and boosted with recombinant gp120 protein. Sera were analyzed for gp120 binding and induction of neutralizing antibody activity. Immunization with recombinant Env protein alone induced low-titer binding antibodies with limited neutralization breath. In contrast, the synthetic DNA prime-protein boost protocol induced significantly higher antibody binding titers. Furthermore, sera from DNA prime-protein boost groups were able to neutralize a broader range of viruses in a panel of tier 1 clade B viruses as well as multiple tier 1 clade A and clade C viruses. Further investigation of synthetic DNA prime plus adaptive EP plus protein boost appears warranted.
40
Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1
Xueling Wu, Zhi-Yong Yang, Yuxing Li et al. · Science · 2010 · 1.8K citations
Structural Basis for Broad and Potent Neutralization of HIV-1 by Antibody VRC01
Tongqing Zhou, Ivelin S. Georgiev, Xueling Wu et al. · Science · 2010 · 1.2K citations
David C. Montefiori, Chitraporn Karnasuta, Yunda Huang et al. · The Journal of Infectious Diseases · 2012 · 284 citations · Full text